首页 › 基金 › VALLEY FORGE INVESTMENT CONSULTANTS INC ADV › SPRY
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 对 SPRY 的持仓历史
ARS PHARMACEUTICALS INC · 医疗保健
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 在 Q2 2026 的 13F 申报中披露持有 SPRY(ARS PHARMACEUTICALS INC)83,225 股,市值约 US$667K,约占其申报组合的 0.17%,在其申报持仓中市值排名第 43 位。 VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 最近 8 个申报季度中有 8 个季度披露了 SPRY 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 对 SPRY 的持仓演变
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 于 Q3 2024 首次披露 SPRY 持仓:83,225 股(约 US$1.2M)。 该持仓在 Q2 2025 达到峰值 83,225 股,市值约 US$1.5M。 在 8 次申报中,VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 83,225 股、市值约 US$667K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 83.22K | $1.21M | 新进 |
| Q4 2024 | 83.22K | $878.02K | 持有 |
| Q1 2025 | 83.22K | $1.05M | 持有 |
| Q2 2025 | 83.22K | $1.45M | 持有 |
| Q3 2025 | 83.22K | $836.41K | 持有 |
| Q4 2025 | 83.22K | $969.57K | 持有 |
| Q1 2026 | 83.22K | $668.30K | 持有 |
| Q2 2026 | 83.22K | $666.63K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SPRY 与 13F 数据
SPRY(ARS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 25 只申报持有 SPRY,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$87.0M), Rubric Capital Management LP (US$68.4M), ORBIMED ADVISORS LLC (US$66.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SPRY 的基金
- RA CAPITAL MANAGEMENT, L.P. 10.86M 股 · $87.00M · Q2 2026
- Rubric Capital Management LP 8.54M 股 · $68.41M · Q2 2026
- ORBIMED ADVISORS LLC 8.29M 股 · $66.39M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 7.50M 股 · $60.11M · Q2 2026
- Tyro Capital Management LLC 4.46M 股 · $35.72M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.01M 股 · $32.14M · Q2 2026
- GENERAL AMERICAN INVESTORS CO INC 1.13M 股 · $9.08M · Q2 2026
- Third Point 1.00M 股 · $8.01M · Q2 2026
- Third Point LLC 1.00M 股 · $8.01M · Q2 2026
- Tejara Capital Ltd 607.04K 股 · $4.86M · Q2 2026
更多关于 VALLEY FORGE INVESTMENT CONSULTANTS INC ADV
常见问题
How long has VALLEY FORGE INVESTMENT CONSULTANTS INC ADV held SPRY?
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV has disclosed SPRY holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is VALLEY FORGE INVESTMENT CONSULTANTS INC ADV's current position in SPRY?
As of Q2 2026, VALLEY FORGE INVESTMENT CONSULTANTS INC ADV holds 83.22K shares of SPRY (ARS PHARMACEUTICALS INC), valued at $666.63K, representing 0.17% of its reported portfolio and ranking #43.
Has VALLEY FORGE INVESTMENT CONSULTANTS INC ADV been buying or selling SPRY?
In the latest 13F filing (Q2 2026), VALLEY FORGE INVESTMENT CONSULTANTS INC ADV held unchanged its position in SPRY. The position peaked in Q2 2025 at 83.22K shares.
Which other funds hold SPRY?
Other major institutional holders of SPRY include RA CAPITAL MANAGEMENT, L.P., Rubric Capital Management LP, ORBIMED ADVISORS LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.